Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis

Tuesday, February 28, 2012 1 min read

Key Takeaway: Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis

Full Press Release Details

Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis.